美股的biotech真是便宜查看全文
网络异常请稍后再试2023-03-02 14:35
$G1治疗(GTHX)$
chuminhua
3小时前
来自 新版微博 weibo.com
3月1日,G1 Therapeutics 周三在其第四季度业绩中披露,其骨髓保护疗法 trilaciclib 对转移性三阴性乳腺癌 (TNBC) 患者的中期总生存期 (OS)...查看全文
牛唐2023-02-14 22:36
医药板块速评(2023.02.13)
1、大药企普遍回调,有哪些公司值得关注?
2、$G1治疗(GTHX)$ 暴跌,是否有抄底机会?
3、$蔚来(NIO)$ 、$苹果(AAPL)$ 期权大量成交,后续走势如何看?查看全文
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004058 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-24-019622 Act: 34 Size: 5 MB 网页链接
$G1 Therapeutics(GTHX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-24-019453 Act: 34 Size: 1 MB 网页链接
$G1 Therapeutics(GTHX)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-113912 Act: 34 Size: 12 MB 网页链接
$G1 Therapeutics(GTHX)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-113902 Act: 34 Size: 4 MB 网页链接
$G1 Therapeutics(GTHX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-113907 Act: 34 Size: 550 KB 网页链接
$G1 Therapeutics(GTHX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-24-094655 Act: 34 Size: 3 MB 网页链接
$G1 Therapeutics(GTHX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003017 Act: 33 Size: 4 KB 网页链接
$G1 Therapeutics(GTHX)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001628280-24-012736 Act: 34 Size: 286 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-002948 Size: 9 KB 网页链接